<SEC-DOCUMENT>0001140361-25-026464.txt : 20250718
<SEC-HEADER>0001140361-25-026464.hdr.sgml : 20250718
<ACCEPTANCE-DATETIME>20250718180627
ACCESSION NUMBER:		0001140361-25-026464
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250716
FILED AS OF DATE:		20250718
DATE AS OF CHANGE:		20250718

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Clemmer James C
		CENTRAL INDEX KEY:			0001476700
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50761
		FILM NUMBER:		251135391

	MAIL ADDRESS:	
		STREET 1:		COVIDIEN PLC
		STREET 2:		15 HAMPSHIRE STREET
		CITY:			MANSFIELD
		STATE:			MA
		ZIP:			02048

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANGIODYNAMICS INC
		CENTRAL INDEX KEY:			0001275187
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				113146460
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	BUSINESS ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
		BUSINESS PHONE:		5187981215

	MAIL ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-07-16</periodOfReport>

    <issuer>
        <issuerCik>0001275187</issuerCik>
        <issuerName>ANGIODYNAMICS INC</issuerName>
        <issuerTradingSymbol>ANGO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001476700</rptOwnerCik>
            <rptOwnerName>Clemmer James C</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>14 PLAZA DRIVE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>LATHAM</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>12110</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>true</isOfficer>
            <officerTitle>President and CEO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-07-16</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>206253</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>887835</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Performance Right</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2025-07-16</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>206253</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>206253</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>206253</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The acquisition of 206,253 shares of common stock (&quot;Common Stock&quot;) of AngioDynamics, Inc. represents 206,253 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029.</footnote>
        <footnote id="F2">Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited.</footnote>
    </footnotes>

    <remarks>Exhibit 24.1 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Lawrence T. Weiss, as Attorney in Fact</signatureName>
        <signatureDate>2025-07-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>ef20052269_ex24-1.htm
<DESCRIPTION>EXHIBIT 24.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="color: #000000; font-size: 10pt; font-weight: bold; text-align: right;">Exhibit 24.1</div>
    <div style="color: #000000; font-size: 10pt; font-weight: bold; text-align: center;"> <br>
    </div>
    <div style="color: #000000; font-size: 10pt; font-weight: bold; text-align: center;">SUBSTITUTE POWER OF ATTORNEY</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Pursuant to the terms of certain Powers of Attorney (the &#8220;Powers of Attorney&#8221;), the undersigned, Stephen A. Trowbridge, was appointed a true and
      lawful attorney-in-fact, with full power of substitution, to do and perform every act and thing whatsoever requisite, necessary or proper to be done in the exercise of the rights and powers granted in such Powers of Attorney, by certain officers and
      directors of AngioDynamics, Inc. (the &#8220;Company&#8221;), including James C. Clemmer (the &#8220;PoA Party&#8221;).</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">Additionally, the Powers of Attorney ratified and confirmed all that such attorney-in-fact, or such attorney-in-fact&#8217;s substitute or substitutes,
      lawfully do or cause to be done by virtue of the Powers of Attorney and the rights and powers granted therein.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 10pt;">In accordance with the authority granted under the Powers of Attorney, including the power of substitution, the undersigned hereby appoints Lawrence
      T. Weiss as a substitute attorney-in-fact, on behalf of the PoA Party, to exercise and execute all of the powers granted or conferred in the applicable Power of Attorney. By his signature as an attorney-in-fact to this Substitute Power of Attorney,
      Lawrence T. Weiss accepts such appointment and agrees to assume from the undersigned any and all duties and responsibilities attendant to his capacity as an attorney-in-fact. This Substitute Power of Attorney supersedes any and all prior Substitute
      Powers of Attorney whereby Stephen A. Trowbridge appointed any individual as a substitute attorney-in-fact on behalf of the PoA Party under the authority granted under the Powers of Attorney.&#160; This Substitute Power of Attorney shall remain in full
      force and effect until the earlier of (i) such time as this Substitute Power of Attorney is revoked by the undersigned, Stephen A. Trowbridge, or by the PoA Party, (ii) such time as this Substitute Power of Attorney is superseded by a new substitute
      power of attorney regarding the purposes outlined herein dated as of a later date, or (iii) such time as the PoA Party is no longer required to file Forms 3, 4, and 5 with respect to such PoA Party&#8217;s holdings of and transactions in securities issued
      by the Company.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-style: italic;">[Signature Page Follows]</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; color: rgb(0, 0, 0); font-size: 10pt;">IN WITNESS WHEREOF, the undersigned has executed this Substitute Power of Attorney this 20th day of January,
      2025.</div>
    <div style="color: #000000; font-size: 10pt; text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z925c9b0d448046a091bf66effc96add9">

        <tr>
          <td style="width: 50%; vertical-align: top; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0);">By:</div>
          </td>
          <td style="width: 45%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Stephen A. Trowbridge</div>
          </td>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0); font-size: 10pt;">Stephen A. Trowbridge</div>
            <div style="color: rgb(0, 0, 0); font-size: 10pt;">Attorney-in-Fact</div>
          </td>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom; font-size: 10pt;">&#160;</td>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0);">I accept this appointment and substitution:</div>
          </td>
          <td style="width: 45%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="font-size: 10pt;">&#160;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Lawrence T. Weiss</div>
          </td>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0);">Lawrence T. Weiss</div>
          </td>
          <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
